• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

5,813
2,294
2,199
2,084
1,932

COUNTRY

1,075
851
272
243
224

CATEGORIES

  • 929
  • 169
  • 112
  • 287
    • 49
  • 473
  • 228
  • 237
  • 53
  • 63
  • 808
  • 1,438
  • 820
  • 18
  • 448
  • 1,380
  • 2,301
    • 82
    • 120
    • 66
    • 66
    • 36
    • 37
    • 11
    • 11
    • 12
    • 18
  • 23
  • 264
  • 39

PRICE

5,776
12,908
21,229
26,431

PUBLISHED

2,411
3,224
8,857
26,431

PRODUCT TYPE

21,814
2,394
1,022
927
164
45
21
19
14
6
4
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE

H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2014

H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2014’, provides an overview of the H5N1 Infection...

June 2014
FROM

Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2014

Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2014’, provides...

June 2014
FROM

Cancer Cachexia - Pipeline Review, H1 2014

Cancer Cachexia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Cancer Cachexia - Pipeline Review, H1 2014’, provides an overview of the Cancer Cachexia’s therapeutic pipeline. This...

June 2014
FROM

Insulin Resistance - Pipeline Review, H1 2014

Insulin Resistance - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Insulin Resistance - Pipeline Review, H1 2014’, provides an overview of the Insulin Resistance’s therapeutic pipeline. This...

June 2014
FROM

Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2014

Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review,...

June 2014
FROM

Sotio a.s. - Product Pipeline Review - 2014

Sotio a.s. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Sotio a.s. - Product Pipeline Review - 2014’, provides an overview of the Sotio a.s.’s pharmaceutical research and development...

June 2014
FROM

DURECT Corporation - Product Pipeline Review - 2014

DURECT Corporation - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘DURECT Corporation - Product Pipeline Review - 2014’, provides an overview of the DURECT Corporation’s pharmaceutical...

June 2014
FROM

D&A Pharma SAS - Product Pipeline Review - 2014

D&A Pharma SAS - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘D&A Pharma SAS - Product Pipeline Review - 2014’, provides an overview of the D&A Pharma SAS’s pharmaceutical research...

June 2014
FROM

GenSight Biologics - Product Pipeline Review - 2014

GenSight Biologics - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘GenSight Biologics - Product Pipeline Review - 2014’, provides an overview of the GenSight Biologics’s pharmaceutical...

June 2014
FROM

Allergic Asthma - Pipeline Review, H1 2014

Allergic Asthma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Allergic Asthma - Pipeline Review, H1 2014’, provides an overview of the Allergic Asthma’s therapeutic pipeline. This...

June 2014
FROM

Anthrax - Pipeline Review, H1 2014

Anthrax - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Anthrax - Pipeline Review, H1 2014’, provides an overview of the Anthrax’s therapeutic pipeline. This report provides comprehensive...

June 2014
FROM

Thyroid Cancer - Pipeline Review, H1 2014

Thyroid Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Thyroid Cancer - Pipeline Review, H1 2014’, provides an overview of the Thyroid Cancer’s therapeutic pipeline. This report...

June 2014
FROM

Burkholderia Infections - Pipeline Review, H1 2014

Burkholderia Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Burkholderia Infections - Pipeline Review, H1 2014’, provides an overview of the Burkholderia Infections’s therapeutic...

June 2014
FROM

Liposarcoma - Pipeline Review, H1 2014

Liposarcoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Liposarcoma - Pipeline Review, H1 2014’, provides an overview of the Liposarcoma’s therapeutic pipeline. This report provides...

June 2014
FROM

Pharmedartis GmbH - Product Pipeline Review - 2014

Pharmedartis GmbH - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Pharmedartis GmbH - Product Pipeline Review - 2014’, provides an overview of the Pharmedartis GmbH’s pharmaceutical...

June 2014
FROM

Senhwa Biosciences, Inc. - Product Pipeline Review - 2014

Senhwa Biosciences, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Senhwa Biosciences - Product Pipeline Review - 2014’, provides an overview of the Senhwa Biosciences’s pharmaceutical...

June 2014
FROM

Guillain-Barre Syndrome Global Clinical Trials Review, H1, 2014

Guillain-Barre Syndrome Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, "Guillain-Barre Syndrome Global Clinical Trials Review, H1, 2014" provides data on the Guillain-Barre...

June 2014
FROM

Dysthymia Global Clinical Trials Review, H1, 2014

Dysthymia Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Dysthymia Global Clinical Trials Review, H1, 2014" provides data on the Dysthymia clinical trial scenario. This...

June 2014
FROM

Pick's Disease Global Clinical Trials Review, H1, 2014

Pick's Disease Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Pick's Disease Global Clinical Trials Review, H1, 2014" provides data on the Pick’s Disease clinical trial...

June 2014
FROM

Encephalopathy Global Clinical Trials Review, H1, 2014

Encephalopathy Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Encephalopathy Global Clinical Trials Review, H1, 2014" provides data on the Encephalopathy clinical trial...

June 2014
FROM
Loading Indicator

Our Clients

Pfizer, Inc. Grünenthal GmbH GlaxoSmithKline PLC Abbott Laboratories Ltd. Roche Diagnostics Ltd. Novo Nordisk A/S